Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,045 | 18 | 53.9% |
| Consulting Fee | $10,875 | 5 | 16.7% |
| Travel and Lodging | $8,667 | 10 | 13.3% |
| Honoraria | $4,750 | 3 | 7.3% |
| Food and Beverage | $4,502 | 93 | 6.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $860.00 | 2 | 1.3% |
| Education | $265.54 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $37,871 | 36 | $0 (2022) |
| Aqua Pharmaceuticals | $12,848 | 24 | $0 (2017) |
| UCB, Inc. | $3,144 | 4 | $0 (2018) |
| Merz North America, Inc. | $2,660 | 21 | $0 (2023) |
| Galderma Laboratories, L.P. | $2,326 | 13 | $0 (2022) |
| Exeltis, USA Inc. | $2,000 | 1 | $0 (2017) |
| Pierre Fabre Pharmaceuticals, Inc. | $2,000 | 1 | $0 (2021) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,004 | 4 | $0 (2023) |
| Solta Medical, a division of Bausch Health US, LLC | $342.68 | 1 | $0 (2023) |
| Allergan, Inc. | $147.37 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.80 | 3 | REVANCE THERAPEUTICS, INC. ($45.49) |
| 2023 | $2,971 | 17 | Merz North America, Inc. ($2,402) |
| 2022 | $158.30 | 4 | ABBVIE INC. ($107.51) |
| 2021 | $2,000 | 1 | Pierre Fabre Pharmaceuticals, Inc. ($2,000) |
| 2020 | $5,427 | 5 | PFIZER INC. ($4,567) |
| 2019 | $7,391 | 9 | PFIZER INC. ($7,250) |
| 2018 | $16,296 | 22 | PFIZER INC. ($12,953) |
| 2017 | $30,664 | 76 | PFIZER INC. ($13,085) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: DERMATOLOGY | ||||||
| 11/29/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO, DUOBRII | Food and Beverage | In-kind items and services | $131.08 | General |
| Category: Podiatry | ||||||
| 10/27/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $21.59 | General |
| 09/23/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $106.42 | General |
| Category: Dermatology | ||||||
| 09/23/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $71.76 | General |
| Category: Dermatology | ||||||
| 09/23/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $60.23 | General |
| Category: Dermatology | ||||||
| 09/23/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $50.89 | General |
| Category: Dermatology | ||||||
| 09/23/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $39.44 | General |
| Category: Dermatology | ||||||
| 09/23/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $37.12 | General |
| Category: Dermatology | ||||||
| 09/22/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $117.96 | General |
| Category: Dermatology | ||||||
| 09/22/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $83.51 | General |
| Category: Dermatology | ||||||
| 09/22/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $53.15 | General |
| Category: Dermatology | ||||||
| 09/22/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $45.34 | General |
| Category: Dermatology | ||||||
| 09/22/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $32.69 | General |
| Category: Dermatology | ||||||
| 09/20/2023 | Merz North America, Inc. | Xeomin (Biological) | Travel and Lodging | Cash or cash equivalent | $1,011.40 | General |
| Category: Dermatology | ||||||
| 09/20/2023 | Merz North America, Inc. | Xeomin (Biological) | Travel and Lodging | Cash or cash equivalent | $670.32 | General |
| Category: Dermatology | ||||||
| 08/05/2023 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $342.68 | General |
| 01/23/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $94.99 | General |
| 10/07/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $107.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/14/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/07/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.02 | General |
| 02/18/2022 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DERMATOLOGY | ||||||
| 06/08/2021 | Pierre Fabre Pharmaceuticals, Inc. | HEMANGEOL (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: PEDIATRIC DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,485 | 4,785 | $1.2M | $384,468 |
| 2022 | 25 | 2,226 | 4,081 | $955,511 | $386,208 |
| 2021 | 25 | 2,296 | 4,003 | $771,388 | $336,740 |
| 2020 | 23 | 2,186 | 4,086 | $693,699 | $281,436 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 648 | 1,090 | $220,309 | $71,494 | 32.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 385 | 574 | $152,437 | $52,849 | 34.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 69 | 87 | $134,322 | $47,939 | 35.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 55 | 107 | $101,274 | $38,768 | 38.3% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 42 | 52 | $75,668 | $28,422 | 37.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 36 | 70 | $63,503 | $24,428 | 38.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 80 | 102 | $71,843 | $23,749 | 33.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 253 | 328 | $78,782 | $22,588 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 254 | 382 | $58,996 | $14,043 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 147 | 147 | $36,537 | $11,590 | 31.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 186 | 1,439 | $23,174 | $8,462 | 36.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 60 | 74 | $41,675 | $8,234 | 19.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 35 | 55 | $21,509 | $7,639 | 35.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 44 | 52 | $14,930 | $4,852 | 32.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 73 | 100 | $11,911 | $4,427 | 37.2% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 11 | 11 | $8,531 | $3,005 | 35.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 18 | 18 | $11,472 | $2,736 | 23.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $6,485 | $2,353 | 36.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 32 | 34 | $8,212 | $2,341 | 28.5% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 12 | 14 | $9,273 | $1,924 | 20.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 12 | 12 | $8,781 | $1,705 | 19.4% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 17 | $3,816 | $920.82 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 628 | 1,026 | $166,430 | $69,283 | 41.6% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 79 | 104 | $132,161 | $52,748 | 39.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 56 | 122 | $94,008 | $45,595 | 48.5% |
About Dr. Samireh Said, MD
Dr. Samireh Said, MD is a Specialist healthcare provider based in Tustin, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336129998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samireh Said, MD has received a total of $64,965 in payments from pharmaceutical and medical device companies, with $58.80 received in 2024. These payments were reported across 137 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,045).
As a Medicare-enrolled provider, Said has provided services to 9,193 Medicare beneficiaries, totaling 16,955 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Tustin, CA
- Active Since 01/19/2006
- Last Updated 11/12/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336129998
Products in Payments
- EUCRISA (Drug) $36,696
- Acticlate (Drug) $5,716
- Veltin (Drug) $4,246
- Xeomin (Biological) $2,498
- Ecoza (Drug) $2,000
- HEMANGEOL (Drug) $2,000
- ORACEA (Drug) $1,308
- MIRVASO (Drug) $900.00
- ARAZLO (Drug) $860.00
- JUBLIA (Drug) $131.08
- DUPIXENT DUPILUMAB INJECTION (Biological) $124.79
- KYBELLA (Biological) $120.56
- BOTOX (Biological) $119.73
- SOOLANTRA (Drug) $88.03
- Xolegel (Drug) $73.75
- Cordran (Drug) $62.14
- Olux (Drug) $61.18
- ONEXTON (Drug) $46.99
- DAXXIFY (Drug) $45.49
- Ceracade (Drug) $20.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Tustin
Charles Oh, M.d, M.D
Specialist — Payments: $6,925
Dr. Rose Marie Pitt, Md, MD
Specialist — Payments: $5,244
Dr. Mark Brown, M.d, M.D
Specialist — Payments: $104.20
Wilfredo Escober, M.d, M.D
Specialist
Khac Quy Nguyen
Specialist
Pia Rotman
Specialist